Premium
Successful recovery from COVID‐19 in three kidney transplant recipients who received convalescent plasma therapy
Author(s) -
Naeem Syed,
Gohh Reginald,
Bayliss George,
Cosgrove Christopher,
Farmakiotis Dimitrios,
Merhi Basma,
Morrissey Paul,
Osband Adena,
Bailey Jeffrey A.,
Sweeney Joseph,
Rogers Ralph
Publication year - 2021
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.13451
Subject(s) - medicine , convalescent plasma , covid-19 , intensive care medicine , clinical trial , kidney transplantation , population , disease , infectious disease (medical specialty) , transplantation , virology , outbreak , environmental health
Novel coronavirus disease 2019 (COVID‐19) is a highly infectious, rapidly spreading viral disease that typically presents with greater severity in patients with underlying medical conditions or those who are immunosuppressed. We present a novel case series of three kidney transplant recipients with COVID‐19 who recovered after receiving COVID‐19 convalescent plasma (CCP) therapy. Physicians should be aware of this potentially useful treatment option. Larger clinical registries and randomized clinical trials should be conducted to further explore the clinical and allograft outcomes associated with CCP use in this population.